Skip to main content
. 2017 Sep 21;8(61):103261–103273. doi: 10.18632/oncotarget.21143

Figure 7. In vivo study of suppressive miR-129.

Figure 7

(A) Tumors acquired from subcutaneously implanted estrogen-treated MCF-7 stem cells of different groups. Overexpressed miR-129 inhibits both tumor weight (B) and tumor growth (C). When combined with either ESR1 inhibition or γ-secretase inhibitor, no significant difference was drawn from signal use and combination of tumor weight (B) and tumor growth (C).